Abstract
In recent years, several sickle cell-specific quality indicators have been developed using rigorous approaches. A review of the history and current status of the development of sickle cell-specific indicators highlights opportunities for future refinement. Despite efforts at alignment, lack of strong evidence hinders the adoption of current quality indicators across stakeholder groups. There are many directions in which to take the current existing quality indicators, including expanding to different age groups, aims of care such as safety and equity, and better understanding of contextual and environmental factors.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 418-422 |
| Number of pages | 5 |
| Journal | Hematology |
| Volume | 2017 |
| Issue number | 1 |
| DOIs | |
| State | Published - Dec 8 2017 |
Fingerprint
ASJC Scopus subject areas
- Hematology
Cite this
Rigorous and practical quality indicators in sickle cell disease care. / Oyeku, Suzette Olu Busola; Faro, Elissa Z.
In: Hematology, Vol. 2017, No. 1, 08.12.2017, p. 418-422.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Rigorous and practical quality indicators in sickle cell disease care
AU - Oyeku, Suzette Olu Busola
AU - Faro, Elissa Z.
PY - 2017/12/8
Y1 - 2017/12/8
N2 - In recent years, several sickle cell-specific quality indicators have been developed using rigorous approaches. A review of the history and current status of the development of sickle cell-specific indicators highlights opportunities for future refinement. Despite efforts at alignment, lack of strong evidence hinders the adoption of current quality indicators across stakeholder groups. There are many directions in which to take the current existing quality indicators, including expanding to different age groups, aims of care such as safety and equity, and better understanding of contextual and environmental factors.
AB - In recent years, several sickle cell-specific quality indicators have been developed using rigorous approaches. A review of the history and current status of the development of sickle cell-specific indicators highlights opportunities for future refinement. Despite efforts at alignment, lack of strong evidence hinders the adoption of current quality indicators across stakeholder groups. There are many directions in which to take the current existing quality indicators, including expanding to different age groups, aims of care such as safety and equity, and better understanding of contextual and environmental factors.
UR - http://www.scopus.com/inward/record.url?scp=85038438117&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038438117&partnerID=8YFLogxK
U2 - 10.1182/asheducation-2017.1.418
DO - 10.1182/asheducation-2017.1.418
M3 - Article
C2 - 29222287
AN - SCOPUS:85038438117
VL - 2017
SP - 418
EP - 422
JO - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program
JF - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program
SN - 1520-4391
IS - 1
ER -